BKL's IF sales are totally miserable - I think it may be wise to cut the loss and consider buying one of the IF players that already building up its earnings
I think BKL buying /merging with BAL has a lot of potential given the similarities in the markets they play at (eg: China, Indonesia) - except IRAN
There would be a lot of synergies that could be generated (eg: Cross promotional materials, distribution footprint, give Infant formula capacity to BAL, etc).
Sometimes - companies needs to do M&A in order to grow rather than have / develop new products to sell.
- Forums
- ASX - By Stock
- BKL
- the new under the oldrse
the new under the oldrse, page-79
-
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BKL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online